Artiva Biotherapeutics, Inc. (ARTV)
ARTV Stock Price Chart
Explore Artiva Biotherapeutics, Inc. interactive price chart. Choose custom timeframes to analyze ARTV price movements and trends.
ARTV Company Profile
Discover essential business fundamentals and corporate details for Artiva Biotherapeutics, Inc. (ARTV) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
—
Employees
96.00
Website
https://www.artivabio.comCEO
Fred Aslan
Description
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. The company's lead product candidate is AB-101, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody-associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, systemic lupus erythematosus, and B-cell-non-Hodgkin lymphoma. It also develops AB-201, an allogeneic anti- human epidermal growth factor receptor 2 chimeric antigen receptor (CAR)-NK cell product candidate; and AB-205, an allogeneic anti-CD5 CAR-NK cell product candidate. The company was incorporated in 2019 and is headquartered in San Diego, California.
ARTV Financial Timeline
Browse a chronological timeline of Artiva Biotherapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.90.
Earnings released on 6 Aug 2025
EPS came in at -$0.87 falling short of the estimated -$0.84 by -3.57%.
Earnings released on 8 May 2025
EPS came in at -$0.83 falling short of the estimated -$0.68 by -22.06%.
Earnings released on 25 Mar 2025
EPS came in at -$0.66 surpassing the estimated -$0.71 by +7.04%.
Earnings released on 12 Nov 2024
EPS came in at -$0.92 falling short of the estimated -$0.68 by -35.29%.
Earnings released on 29 Aug 2024
EPS came in at -$22.00 falling short of the estimated -$4.40 by -400.00%, while revenue for the quarter reached $251.00K .
Earnings released on 30 Jun 2024
EPS came in at -$0.62 .
Earnings released on 31 Dec 2023
EPS came in at -$0.30 , while revenue for the quarter reached $33.49M .
Earnings released on 30 Sept 2023
EPS came in at $1.20 , while revenue for the quarter reached $26.66M .
Earnings released on 30 Jun 2023
EPS came in at -$0.90 .
Earnings released on 31 Mar 2023
EPS came in at -$0.95 , while revenue for the quarter reached $989.00K .
ARTV Stock Performance
Access detailed ARTV performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.